ASCO 2010 - Poster Sessions by Antisoma


AS1411

Saturday June 5, 8:00 AM to 12:00 PM
http://abstract.asco.org/AbstView_74_49933.html
Long-term outcomes of responders in a randomized, controlled phase II trial of aptamer AS1411 in AML.

Monday June 7, 8:00 AM to 12:00 PM
http://abstract.asco.org/AbstView_74_49960.html
A multicenter dose-finding randomized controlled phase IIb study of the aptamer AS1411 in patients with primary refractory or relapsed AML.

Monday June 7, 1:00 PM to 5:00 PM
http://abstract.asco.org/AbstView_74_49790.html
A phase II, single-arm study of AS1411 in metastatic renal cell carcinoma (RCC).


AS1413

Monday June 7, 8:00 AM to 12:00 PM
http://abstract.asco.org/AbstView_74_49982.html
A phase IIa pharmacokinetic and efficacy study of amonafide (AS1413) in combination with cytarabine in patients with acute myeloid leukemia.